SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Maiden Holdings, Ltd. of Class Action Lawsuit and Upcoming Deadline – MHLD
NEW YORK, March 21, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Maiden Holdings, Ltd. (“Maiden” or the “Company”) (NASDAQ: MHLD) and certain of its officers and directors. The class action, filed in United States District Court, District of New Jersey, and indexed under 19-cv-08105, is on behalf of a class consisting of all persons and entities, other than Defendants and their affiliates, who purchased or otherwise acquired publicly traded securities of, Maiden securities between March 4, 2014 and November 9, 2018 (the “Class Period”), against Maiden and certain of the Company’s former executive officers seeking to pursue remedies under the Securities Exchange Act of 1934 (the “Exchange Act”).
If you are a shareholder who purchased Maiden securities during the class period, you have until April 12, 2019, to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at firstname.lastname@example.org or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Maiden is a Bermuda-based holding company that provides reinsurance services through its subsidiaries. Reinsurance is the process by which one insurance company insures policies underwritten by another insurance company, allowing that company to mitigate its risk in the event of adverse developments that may cause policy losses. The insurance company pays premiums to the reinsurance company and, if a loss triggered under the reinsurance policy develops, the insurance company can cede the agreed upon amount of loss to the reinsurer.
Because Maiden is a reinsurance company, the reliability of the underwriting procedures and processes it uses to evaluate the underlying policies it reinsures are critical to the Company’s success. It is of central importance to investors that Maiden accurately assess and disclose potential risks and liabilities related to these underlying policies and, further, that the Company appropriately prices its reinsurance policies to account for such risks, establish adequate loss reserves, and avoid adverse developments and unexpected losses.
Maiden has two reportable operating segments: (i) Diversified Reinsurance; and (ii) AmTrust Reinsurance. The Diversified Reinsurance segment consists of a portfolio of predominantly property and casualty reinsurance business focusing on regional and specialty property and casualty insurance companies. The AmTrust Reinsurance segment includes all business ceded by AmTrust Financial Services, Inc. (“AmTrust”).
AmTrust and Maiden are closely-related entities, with Maiden noting in financial filings that it “may be deemed an affiliate of AmTrust.” AmTrust was founded in 1998 by the brothers Michael Karfunkel (“M. Karfunkel”) and George Karfunkel (“G. Karfunkel”). AmTrust underwrites and provides various niche property and casualty insurance products.
Similarly, Maiden was formed in 2007 by M. Karfunkel, G. Karfunkel, and M. Karfunkel’s son-in-law, Barry Zyskind (“Zyskind”), primarily to provide reinsurance services to AmTrust. Zyskind is the current Chairman of the Board of Directors for Maiden (the “Board”), as well as the CEO, President, and Chairman of AmTrust. Members of the Karfunkel family are also principal stockholders of AmTrust and owned or controlled about 49% of AmTrust’s outstanding common shares as of December 31, 2016. The complaint alleges throughout the Class Period, defendants misrepresented the quality and nature of Maiden’s underwriting and risk management policies and practices and the risks of its reinsurance portfolio. In particular, defendants misleadingly claimed that they were subjecting AmTrust’s insurance portfolio to robust analysis and cross-checks to ensure that the Company had appropriately priced the risk of reinsuring AmTrust’s insurance portfolio. In truth, the Company had failed to employ sufficient underwriting and risk management protocols and had largely abdicated its responsibility to ensure that its AmTrust Reinsurance segment priced policies commensurate with the risk assumed by the Company. These failures subjected the Company, and investors, to catastrophic losses. As those losses were realized, the price of Maiden stock declined precipitously. On February 27, 2018, Maiden reported a net loss of $133.6 million and a net adverse development of $171 million stemming from the Company’s workers’ compensation line of its AmTrust Reinsurance segment and from two accounts in its commercial auto line of business within the Diversified Reinsurance segment. On this news, Maiden’s stock price fell $1.20 per share, or 16%, to close at $6.00 per share on February 28, 2018. On August 9, 2018, Maiden announced its financial results for the quarter ended June 30, 2018, revealing that it had continued to sustain losses, suffering a net loss of $5.9 million for the quarter, and disclosing that Maiden had suffered an adverse prior year loss development of $28.4 million in its AmTrust Reinsurance segment. The Company also revealed that its Chief Executive Officer and Chief Financial Officer would be retiring.
On this news, the price of Maiden common stock fell $3.10 per share, or 41.3%, to close at $4.40 per share on August 9, 2018. Then, on November 9, 2018, Maiden announced its financial results for the quarter ended September 30, 2018, including a massive $308.8 million net loss and a $210.4 million adverse prior year loss development in just its AmTrust segment. The Company also revealed that the sale of Maiden’s business assets had resulted in an impairment loss of $74.2 million. On this news, the price of Maiden common stock fell $1.12 per share, or nearly 32%, to close at $2.40 per share on November 12, 2018.
The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.
Robert S. WilloughbyPomerantz LLP email@example.com 888-476-6529 ext. 9980